Drug Markets/Zolmitriptan

Zolmitriptan

28 NDCs across 13 manufacturers|26 Generic,2 Brand

Zolmitriptan is used to treat migraine disorders, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Nov 25, 1997, and the first generic was approved May 14, 2013. FDA's Orange Book lists 30 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $8 million on Zolmitriptan across 53,000 claims for 14,000 beneficiaries.

Zolmitriptan is available as 28 NDCs from 13 manufacturers (26 generic, 2 brand), with NADAC prices from $1.01 to $108.73 per EA — the most expensive product costs about 108× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

28

26G / 2B

Manufacturers

13

competing in market

Price Spread

$1.01 – $108.73

per EA

7d Activity

17↑5↓6 flat

avg +2.9% WoW · of 28 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

28 NDCs total, 28 shown

WatchDrug ↕Price 7d Change ↕
ZOMIG 5 MG NASAL SPRAY
$108.7267
per EA
-0.06%
ZOMIG 2.5 MG NASAL SPRAY
$108.5647
per EA
—
ZOLMITRIPTAN 5 MG NASAL SPRAY
$49.3568
per EA
+2.84%
ZOLMITRIPTAN 5 MG NASAL SPRAY
$49.3568
per EA
+2.84%
ZOLMITRIPTAN 5 MG ODT
$3.4143
per EA
-6.66%
ZOLMITRIPTAN 5 MG ODT
$3.4143
per EA
-6.66%
ZOLMITRIPTAN 5 MG ODT
$3.4143
per EA
-6.66%
ZOLMITRIPTAN 5 MG ODT
$3.4143
per EA
-6.66%
ZOLMITRIPTAN 2.5 MG ODT
$2.6047
per EA
—
ZOLMITRIPTAN 2.5 MG ODT
$2.4655
per EA
+7.99%
ZOLMITRIPTAN 2.5 MG ODT
$2.4655
per EA
+7.99%
ZOLMITRIPTAN 2.5 MG ODT
$2.4655
per EA
+7.99%
ZOLMITRIPTAN 5 MG TABLET
$2.1296
per EA
—
ZOLMITRIPTAN 5 MG TABLET
$1.4918
per EA
—
ZOLMITRIPTAN 5 MG TABLET
$1.3660
per EA
+2.13%
ZOLMITRIPTAN 5 MG TABLET
$1.3660
per EA
+2.13%
ZOLMITRIPTAN 5 MG TABLET
$1.3660
per EA
+2.13%
ZOLMITRIPTAN 5 MG TABLET
$1.3660
per EA
+2.13%
ZOLMITRIPTAN 5 MG TABLET
$1.3660
per EA
+2.13%
ZOLMITRIPTAN 5 MG TABLET
$1.3660
per EA
+2.13%
ZOLMITRIPTAN 2.5 MG TABLET
$1.3217
per EA
—
ZOLMITRIPTAN 2.5 MG TABLET
$1.1968
per EA
—
ZOLMITRIPTAN 2.5 MG TABLET
$1.0074
per EA
+8.05%
ZOLMITRIPTAN 2.5 MG TABLET
$1.0074
per EA
+8.05%
ZOLMITRIPTAN 2.5 MG TABLET
$1.0074
per EA
+8.05%
ZOLMITRIPTAN 2.5 MG TABLET
$1.0074
per EA
+8.05%
ZOLMITRIPTAN 2.5 MG TABLET
$1.0074
per EA
+8.05%
ZOLMITRIPTAN 2.5 MG TABLET
$1.0074
per EA
+8.05%

Frequently Asked Questions

What is Zolmitriptan used to treat?

Zolmitriptan is used to treat migraine disorders, per the National Library of Medicine's MED-RT classification.

When did Zolmitriptan become available as a generic?

FDA approved the first generic Zolmitriptan (ANDA) on May 14, 2013. The Orange Book currently lists 30 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Zolmitriptan?

In 2024, Medicare Part D spent $8 million on Zolmitriptan across 53,000 claims for 14,000 beneficiaries.

How many Zolmitriptan products are on the market?

The Zolmitriptan drug market contains 28 NDCs from 13 manufacturers — 26 generic and 2 brand products.

What is the price range for Zolmitriptan?

NADAC reference prices for Zolmitriptan range from $1.0074 to $108.7267 per EA — the most expensive product costs about 108× the cheapest.

Is generic Zolmitriptan cheaper than brand?

The average generic NADAC for Zolmitriptan is $5.4905 per EA, versus $108.6457 for brand-labeled products — brand versions average about 20× the generic price.

Which manufacturers make Zolmitriptan?

13 manufacturers list Zolmitriptan in NADAC. Ranked by number of NDCs, the largest are Glenmark Pharmaceuticals Inc., USA (4), Alembic Pharmaceuticals Inc. (4), Amneal Pharmaceuticals LLC (2), Jubilant Cadista Pharmaceuticals Inc. (2), Zydus Pharmaceuticals (USA) Inc. (2).

How has the price of Zolmitriptan changed recently?

Over the past 7 days, 17 Zolmitriptan NDCs rose and 5 fell, with a market-wide average change of +2.9%.